5
ZTS
ZOETIS, INC. · Health Care
Consensus score 5/100 · #95 this quarter · tier-weighted across tracked managers
Cluster buy: 3 tracked managers opened a new ZTS position this quarter.
↓DivergingPrice action since filingas of 2026-09-30
vs 50-day avg
-6.4%
21-day momentum
-9.7%
recent volume
0.69×
13F filings lag ~45 days; this is current price/volume action on top — a technical read, not a prediction.
S4· DecliningStage Analysis · Weinstein
vs 30-wk avg
-26.7%
30-wk MA slope
-7.0%
rel. strength
-43.1
52-wk range
0%
Declining — below a falling 30-week trend, lagging the market. Weinstein says avoid. Based on the 30-week (150-day) moving average + slope, Mansfield relative strength vs SPY, and volume. Technical read, not advice.
Holders
5
tracked managers
New this Q
3
opened a position
Avg weight
1.6%
of their portfolios
Combined value
$325M
held, at quarter-end
Who’s holding it Q2 2026, by position size
| Manager | Position size | Value | Change |
|---|---|---|---|
| Tweedy Browne Graham/global value | 3.0% | $40M | NEW |
| Ruane Cunniff / Sequoia Quality compounder | 2.6% | $169M | TRIM |
| Smead Capital Concentrated | 1.9% | $89M | NEW |
| Polen Capital Quality growth | 0.2% | $23M | TRIM |
| Markel Group Concentrated | 0.0% | $5M | NEW |
Position size = share of that manager’s reported long US-equity portfolio. The consensus score weights each holder by quality tier, position size, and whether they were buying or trimming — then discounts very crowded names. It measures agreement among these managers, not expected return.